Stem Cell’s – Business Proposition to be proven

California’s $3 billion effort has just begun (2007) — and this article from the San Jose Mercury News points out that profits are long term, not short term, because:

  1. Ethical/moral arguments surrounding stem cell research
  2. So little is known, basic research is the first recipient of funds
  3. Risky process of developing product keeps investors at bay
  4. Two companies, Geron and Advanced Cell, hold many of the patents for human embryonic stem cell research and associated technologies.

However, there are eternal optimists:

“You’ll see more companies forming around embryonic work,” said Gregory Bonfiglio, managing partner of Palo Alto-based Proteus Venture Partners, which plans to invest in such firms. “This technology will fundamentally change health care.”

Leave a comment

Filed under stem cell

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s